急性脊髓损伤患者脑脊液引流:多中心随机对照试验
该多中心随机对照试验纳入急性颈椎脊髓损伤24小时内患者11例,随机分为对照组(仅升高平均动脉压)和实验组(升高平均动脉压联合脑脊液引流,目标使鞘内压<10 mmHg持续5天),结果显示脑脊液引流安全,可降低鞘内压并显著改善脊髓灌注压。
要点
- 脑脊液引流组鞘内压均值5.3±2.5 mmHg,对照组15±3.0 mmHg。
- 脊髓灌注压从对照组77±4.5 mmHg改善至脑脊液引流组101±6.3 mmHg(P<0.01)。
- 180天内总运动评分对照组提高15±8.4分,脑脊液引流组提高57±24分。
核心结论
- 脑脊液引流是急性脊髓损伤后降低鞘内压、改善脊髓灌注压的安全有效机制。
- 良好的安全性和初步疗效应有助于推动未来研究的招募。
研究设计与样本
- 多中心随机对照试验,纳入急性颈椎脊髓损伤24小时内患者。
- 所有患者接受腰椎引流置入和适当的减压手术。
- 对照组仅接受平均动脉压升高,实验组接受平均动脉压升高联合脑脊液引流,目标使鞘内压<10 mmHg持续5天。
- 每小时记录鞘内压和平均动脉压,记录不良事件,并在入组时、伤后72小时、90天和180天进行功能评估。
主要发现
- 共纳入11例患者,其中4例随机分配至脑脊液引流组。
- 脑脊液引流组鞘内压均值5.3±2.5 mmHg,对照组15±3.0 mmHg。
- 脊髓灌注压从对照组77±4.5 mmHg改善至脑脊液引流组101±6.3 mmHg(P<0.01)。
- 180天内总运动评分对照组提高15±8.4分,脑脊液引流组提高57±24分。
- 无不良事件归因于脑脊液引流。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The secondary phase of spinal cord injury (SCI) is characterized by ischemic injury. Spinal cord perfusion pressure (SCPP), calculated as the difference between mean arterial pressure (MAP) and intrathecal pressure (ITP), has arisen as a therapeutic target for improving outcomes. Cerebrospinal fluid drainage (CSFD) may reduce ITP and thereby increase SCPP. Randomized controlled trial to evaluate the safety and feasibility of CSFD to improve SCPP and outcomes after acute SCI. METHODS: Inclusion criteria included acute cervical SCI within 24 hours of presentation. All patients received lumbar drain placement and appropriate decompressive surgery. Patients randomized to the control group received MAP elevation only. Patients in the experimental group received MAP elevation and CSFD to achieve ITP <10 mmHg for 5 days. ITP and MAP were recorded hourly. Adverse events were documented and patients underwent functional assessments at enrollment, 72 hours, 90 days, and 180 days post-injury. RESULTS: Eleven patients were enrolled; 4 were randomized to receive CSFD. CSFD patients had a mean ITP of 5.3 ± 2.5 mmHg versus. 15 ± 3.0 mmHg in the control group. SCPP improved significantly, from 77 ± 4.5 mmHg in the control group to 101 ± 6.3 mmHg in the CSFD group (P < 0.01). Total motor scores improved by 15 ± 8.4 and 57 ± 24 points in the control and CSFD groups, respectively, over 180 days. No adverse events were attributable to CSFD. CONCLUSIONS: CSFD is a safe, effective mechanism for reducing ITP and improving SCPP in the acute period post-SCI. The favorable safety profile and preliminary efficacy should help drive recruitment in future studies.
引用
- Theodore N, Martirosyan N, Hersh AM, et al. Cerebrospinal Fluid Drainage in Patients with Acute Spinal Cord Injury: A Multi-Center Randomized Controlled Trial. World Neurosurg. 2023. PMID: 37356491. doi:10.1016/j.wneu.2023.06.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。